Skip to Content
Diagnosed with ulcerative colitis? Learn about biologics >>

Atropine / hyoscyamine / phenobarbital / scopolamine Pregnancy and Breastfeeding Warnings

Atropine / hyoscyamine / phenobarbital / scopolamine is also known as: Alkabel-SR, Antispas, Antispasmodic, Barbidonna, Bellalphen, Bellatal, Bellatal ER, Chardonna-2, D-Tal, Donnaphen, Donnapine, Donnatal, Donnatal Extentabs, Elixiral, Haponal, Hyosophen, Kinesed, PB-Hyos, Quadrapax, RE-PB Hyos Elixir, Servira, Spasmolin, Spasquid, Vitetal

Atropine / hyoscyamine / phenobarbital / scopolamine Pregnancy Warnings

Atropine/hyoscyamine/phenobarbital/scopolamine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Atropine/hyoscyamine/phenobarbital/scopolamine should be given to a pregnant woman only if clearly needed.

Atropine / hyoscyamine / phenobarbital / scopolamine Breastfeeding Warnings

There is no data on the excretion of atropine/hyoscyamine/phenobarbital/scopolamine into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering atropine/hyoscyamine/phenobarbital/scopolamine to nursing women.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.